|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gray R, Barnwell J, McConkey C, Hills RK,
Williams NS, Kerr DJ and Group QC: Adjuvant chemotherapy vs.
observation in patients with colorectal cancer: A randomised study.
Lancet. 370:2020–2029. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agre P: The aquaporin water channels. Proc
Am Thorac Soc. 3:5–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kruse E, Uehlein N and Kaldenhoff R: The
aquaporins. Genome Biol. 7:2062006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Verkman AS: Aquaporins. Curr Biol.
23:R52–R55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ribatti D, Ranieri G, Annese T and Nico B:
Aquaporins in cancer. Biochim Biophys Acta. 1840:1550–1553. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Verkman AS, Anderson MO and Papadopoulos
MC: Aquaporins: Important but elusive drug targets. Nat Rev Drug
Discov. 13:259–277. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Zhang Y, Wu X and Yu G:
Aquaporins: New targets for cancer therapy. Technol Cancer Res
Treat. 15:821–828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Feng L, Zhu Z, Zheng M, Wang D,
Chen Z and Sun H: Aquaporins as diagnostic and therapeutic targets
in cancer: How far we are? J Transl Med. 13:962015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang Y: Aquaporin-1 activity of plasma
membrane affects HT20 colon cancer cell migration. IUBMB Life.
61:1001–1009. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei X and Dong J: Aquaporin 1 promotes the
proliferation and migration of lung cancer cell in vitro. Oncol
Rep. 34:1440–1448. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yun S, Sun PL, Jin Y, Kim H, Park E, Park
SY, Lee K and Chung JH: Aquaporin 1 is an independent marker of
poor prognosis in lung adenocarcinoma. J Pathol Transl Med.
50:251–257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin F, Zhang H, Shao Y, Liu X, Yang L,
Huang Y, Fu L, Gu F and Ma Y: Expression of aquaporin1, a water
channel protein, in cytoplasm is negatively correlated with
prognosis of breast cancer patients. Oncotarget. 7:8143–8154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang BW, Kim JG, Lee SJ, Chae YS and Jeong
JY, Yoon GS, Park SY, Kim HJ, Park JS, Choi GS and Jeong JY:
Expression of aquaporin-1, aquaporin-3 and aquaporin-5 correlates
with nodal metastasis in colon cancer. Oncology. 88:369–376. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu YH and Zhu WL: Effects of cetuximab
combined with afatinib on the expression of KDR and AQP1 in lung
cancer. Genet Mol Res. 14:16652–16661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xuejun C, Weimin C, Xiaoyan D, Wei Z,
Qiong Z and Jianhua Y: Effects of aquaporins on chemosensitivity to
cisplatin in ovarian cancer cells. Arch Gynecol Obstet.
290:525–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshida T, Hojo S, Sekine S, Sawada S,
Okumura T, Nagata T, Shimada Y and Tsukada K: Expression of
aquaporin-1 is a poor prognostic factor for stage II and III colon
cancer. Mol Clin Oncol. 1:953–958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union against Cancer: TNM classification of
malignant tumours. Wiley-Blackwell Chichester; West Sussex, UK;
Hoboken NJ: 2010
|
|
22
|
Dorward HS, Du A, Bruhn MA, Wrin J, Pei
JV, Evdokiou A, Price TJ, Yool AJ and Hardingham JE:
Pharmacological blockade of aquaporin-1 water channel by AqB013
restricts migration and invasiveness of colon cancer cells and
prevents endothelial tube formation in vitro. J Exp Clin Cancer
Res. 35:362016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moon C, Soria JC, Jang SJ, Lee J, Hoque
Obaidul M, Sibony M, Trink B, Chang YS, Sidransky D and Mao L:
Involvement of aquaporins in colorectal carcinogenesis. Oncogene.
22:6699–6703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Machida Y, Ueda Y, Shimasaki M, Sato K,
Sagawa M, Katsuda S and Sakuma T: Relationship of aquaporin 1, 3
and 5 expression in lung cancer cells to cellular differentiation,
invasive growth and metastasis potential. Hum Pathol. 42:669–678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Otterbach F, Callies R, Adamzik M, Kimmig
R, Siffert W, Schmid KW and Bankfalvi A: Aquaporin 1 (AQP1)
expression is a novel characteristic feature of a particularly
aggressive subgroup of basal-like breast carcinomas. Breast Cancer
Res Treat. 120:67–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Willis S, Villalobos VM, Gevaert O,
Abramovitz M, Williams C, Sikic BI and Leyland-Jones B: Single gene
prognostic biomarkers in ovarian cancer: A meta-analysis. PLoS One.
11:e01491832016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Imrédi E, Tóth B, Doma V, Barbai T, Rásó
E, Kenessey I and Tímár J: Aquaporin 1 protein expression is
associated with BRAF V600 mutation and adverse prognosis in
cutaneous melanoma. Melanoma Res. 26:254–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deb P, Pal S, Dutta V, Boruah D, Chandran
VM and Bhatoe HS: Correlation of expression pattern of aquaporin-1
in primary central nervous system tumors with tumor type, grade,
proliferation, microvessel density, contrast-enhancement and
perilesional edema. J Cancer Res Ther. 8:571–577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saadoun S, Papadopoulos MC, Davies DC,
Bell BA and Krishna S: Increased aquaporin 1 water channel
expression in human brain tumours. Br J Cancer. 87:621–623. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen Q, Lin W, Luo H, Zhao C, Cheng H,
Jiang W and Zhu X: Differential expression of aquaporins in
cervical precursor lesions and invasive cervical cancer. Reprod
Sci. 23:1551–1558. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Y, Murakami T, Sano F, Kondo K,
Nakaigawa N, Kishida T, Kubota Y, Nagashima Y and Yao M: Expression
of aquaporin 1 in primary renal tumors: A prognostic indicator for
clear-cell renal cell carcinoma. Eur Urol. 56:690–698. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kao SC, Armstrong N, Condon B, Griggs K,
McCaughan B, Maltby S, Wilson A, Henderson DW and Klebe S:
Aquaporin 1 is an independent prognostic factor in pleural
malignant mesothelioma. Cancer. 118:2952–2961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sekine S, Shimada Y, Nagata T, Moriyama M,
Omura T, Watanabe T, Hori R, Yoshioka I, Okumura T, Sawada S, et
al: Prognostic significance of aquaporins in human biliary tract
carcinoma. Oncol Rep. 27:1741–1747. 2012.PubMed/NCBI
|
|
34
|
Pan XY, Guo H, Han J, Hao F, An Y, Xu Y,
Xiaokaiti Y, Pan Y and Li XJ: Ginsenoside Rg3 attenuates cell
migration via inhibition of aquaporin 1 expression in PC-3M
prostate cancer cells. Eur J Pharmacol. 683:27–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
André T, Boni C, Navarro M, Tabernero J,
Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F
and de Gramont A: Improved overall survival with oxaliplatin,
fluorouracil and leucovorin as adjuvant treatment in stage II or
III colon cancer in the MOSAIC trial. J Clin Oncol. 27:3109–3116.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meropol NJ: Ongoing challenge of stage II
colon cancer. J Clin Oncol. 29:3346–3348. 2011. View Article : Google Scholar : PubMed/NCBI
|
